Global Non-Invasive Prenatal Testing Market is expected to reach $11.62 billion by 2027 growing at a CAGR 14.5% during 2018 to 2027.

VCNN Editor Avatar

Some of the key players in Non-Invasive Prenatal Testing Market include Illumina, Inc , Thermo Fisher Scientific, Inc, GE Healthcare, Perkinelmer Inc, Yourgene Health, Quest Diagnostics, Sequenom, Bioarray S.L, Berry Genomics and LifeCodexx AG.

Gaithersburg, Maryland, United States – April 24, 2020 /MarketersMedia/

Some of the key factors such as increasing programs related to awareness and growing maternal period are driving the market growth. However, lack of capable professionals is the restraining factor for the growth of the market.

Request for sample here: https://www.strategymrc.com/report/non-invasive-prenatal-testing-market/request-sample

Non-invasive prenatal testing is as well known as non-invasive parenteral screening, which is a hopeful genetic method of investigative a fetal cell free DNA there in the mothers blood serum for detecting general fetal aneuploidies. Its most important purpose is early recognition of genetic disorders such as trisomy 18 (Edward syndrome), trisomy 21 (Down syndrome), and monosomy X (Turner syndrome). It can as well distinguish the blood group and rhesus actor of the fetus.

By method, down syndrome (Trisomy 21) segment is likely to have a huge demand as it includes positive birth defects, education problems, and facial description. A child with Down syndrome can also contain heart defects and trouble with vision and hearing. According to the centres for illness control and prevention, it is the mostly general chromosomal situation diagnosed in United States. Every year, about six thousands babies born in the United States have Down syndrome. This way that Down syndrome occurs in about one out of each seven hundred babies.

Access the complete report at: https://www.strategymrc.com/report/non-invasive-prenatal-testing-market

On the basis of geography, North America is going to have a lucrative growth during the forecast period due to favourable compensation policies and rise in the occurrence of genetic disorders. This will enlarge the acceptance and command for tests in this region.

Make an inquiry at: https://www.strategymrc.com/report/non-invasive-prenatal-testing-market

Methods Covered:
• Microdeletion Syndrome
• Trisomy
• Turner Syndrome
• Cell-Free DNA in Maternal Plasma Tests
• Biochemical Screening Tests
• Sex Chromosomes Disorders
• Ultrasound Screening
• Fetal Cells in Maternal Blood Tests
• Other Methods

Products Covered:
• Consumables
• Instruments
• Services
• Software

Gestation Periods Covered:
• 25-36 weeks
• 0-12 weeks
• 13-24 weeks

Risk-Types Covered:
• Low Risk
• High & Average Risk

Test Types Covered:
• Verifi Test
• MaterniT21 PLUS Test
• NIFTY Test
• Harmony Test
• PrenaTest
• Panorama Test
• Sequenom Test
• IONA Test
• Bambni Test

End Users Covered:
• Hospitals
• Diagnostic Laboratories
• Academic and Research Institutes

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
– Market share assessments for the regional and country level segments
– Market share analysis of the top industry players
– Strategic recommendations for the new entrants
– Market forecasts for a minimum of 9 years of all the mentioned segments, sub-segments, and the regional markets
– Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
– Strategic recommendations in key business segments based on the market estimations
– Competitive landscaping mapping the key common trends
– Company profiling with detailed strategies, financials, and recent developments
– Supply chain trends mapping the latest technological advancements

Follow us on Twitter: https://twitter.com/StratisticsMRC

Follow us on LinkedIn at: https://www.linkedin.com/company/stratistics-market-research-consulting-pvt-ltd?trk=mini-profile

About Stratistics MRC
We offer a wide spectrum of research and consulting services with in-depth knowledge of different industries. We are known for customized research services, consulting services, and Full-Time Equivalent (FTE) services in the research world. We explore market trends and draw our insights with valid assessments and analytical views. We use advanced techniques and tools among the quantitative and qualitative methodologies to identify the market trends.

Our research reports and publications are routed to help our clients to design their business models and enhance their business growth in the competitive market scenario. We have a strong team with hand-picked consultants including project managers, implementers, industry experts, researchers, research evaluators and analysts with years of experience in delivering the complex projects.

Contact Info:
Name: James Lamb
Email: Send Email
Organization: Stratistics Market Research Consulting Pvt Ltd
Phone: +1-301-202-5929
Website: https://www.strategymrc.com/

Source URL: https://marketersmedia.com/global-non-invasive-prenatal-testing-market-is-expected-to-reach-1162-billion-by-2027-growing-at-a-cagr-145-during-2018-to-2027/88955075

Source: MarketersMedia

Release ID: 88955075

VCNN Editor Avatar
Search
Categories